Construction of a Pharmaceutical Production Facility
Find out how Alps Group helped TRB Chemedica create a GMP production line to manufacture an active ingredient against Parkinson's disease.

Context
TRB Chemedica, a leader in rheumatology, ophthalmology, and neurology, selected its Vouvry site to manufacture an active ingredient to treat Parkinson’s disease. The new GMP-compliant production line was designed to be flexible, adapting to market evolutions while meeting the stringent requirements of the pharmaceutical industry.
Design of a flexible pharmaceutical production facility
Design a pharmaceutical production facility control system ensuring compliance with GMP standards and efficient management of ATEX zones (explosive areas).

Achievements
Alps Group completed several key steps in this strategic project:
- Detailed study of electrical needs, followed by the dimensioning of necessary installations and wiring diagram creation
- Manufacture of custom electrical cabinets, including for pneumatic systems, tailored to the project’s constraints and ATEX zones
- Installation of an innovative distribution cell, with a ControlNet communication bus to optimize energy management and ensure communication between system components
Commissioning and obtaining SwissMedic certification, allowing the new production line to quickly meet TRB Chemedica’s needs.